Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07070011Recruiting
Studying tiny particles in blood to predict treatment response in lung cancer
This trial looks at small particles called extracellular vesicles in your blood to see if they can help predict how well immunotherapy combined with chemotherapy will work for extensive-stage small cell lung cancer. The goal is to find markers that could guide future treatment decisions.
ShanghaiAges 45–80 - NCT07070323RecruitingPhase 1/Phase 2
Nanobody CD5-CAR T cells for T-cell cancers
This trial tests a new treatment using your own or a donor's immune cells to fight certain T-cell cancers that haven't responded to standard therapies. It may help people who have few other options left.
Beijing, Beijing MunicipalityAges 1–70 - NCT07070622RecruitingPhase 3
Organ preservation for low rectal cancer after chemo
This trial tests whether chemotherapy alone can help avoid surgery for low rectal cancer. It is for people with tumors close to the anus that haven't spread far, and who haven't had prior cancer treatment.
Chengdu, SichuanAges 18–80 - NCT07070596Recruiting
Studying celiac disease and related gut conditions
This study collects information from people being checked for celiac disease to better understand the condition and improve diagnosis and treatment.
Terrassa, BarcelonaAges Any age - NCT07071402Recruiting
Ultrasound-guided vacuum removal plus surgery for early small breast cancer
This trial tests a less invasive approach for early breast cancer. First, doctors use ultrasound to guide a vacuum device to remove the small tumor (≤2 cm). Then surgery is done. The goal is to see if this combined method works well and is safe for women with early-stage breast cancer.
Xi'an, ShaanxiAges 18–70 - NCT07071818Recruiting
Ultrasound and urine leak after vaginal closure surgery
This study looks at whether a specific ultrasound measurement can predict new urine leakage after a surgery that closes the vagina (colpocleisis) for severe prolapse. It may help women who are not planning future intercourse understand their risk of leaking urine after the procedure.
IstanbulAges 60–75 - NCT07071948Recruiting
Study of VISOR for kidney stone treatment
This trial tests a new device called VISOR to help break up kidney stones using a flexible tube and laser. It's for adults aged 18–80 with stones between 1 and 3 cm who haven't had previous kidney surgery.
Hangzhou, ZhejiangAges 18–80 - NCT07071987Recruiting
Acupuncture for bowel recovery after colon cancer surgery
This trial tests if thread embedding acupuncture can help your bowels start working again faster after surgery for colorectal cancer. It may reduce discomfort and speed up recovery.
Yangzhou, JiangsuAges 18–80 - NCT07072169RecruitingPhase 1
Testing an mRNA therapy for relapsed B-cell lymphoma
This trial tests a new mRNA treatment that helps your immune cells target and attack lymphoma cells. It's for people whose B-cell non-Hodgkin lymphoma has come back or not responded to prior treatments.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07072208Recruiting
A Study of Four Drugs for Older Adults with DLBCL
This trial tests a combination of four medications (pomalidomide, rituximab, orelabrutinib, and polatuzumab vedotin) for newly diagnosed, elderly patients with diffuse large B-cell lymphoma (DLBCL) who cannot tolerate standard treatments. It aims to see if this combination is effective and safe for older adults.
Suzhou, JiangsuAges 70 years+ - NCT07072247RecruitingPhase 1
RN1201 injection for hard-to-treat antibody-mediated blood disorders
This trial tests a new injection called RN1201 for people with antibody-mediated diseases, specifically two types of blood disorders: platelet transfusion refractoriness (PTR) and immune thrombocytopenia (ITP) that haven't responded to standard treatments. The goal is to see if RN1201 can help control these conditions.
Suzhou, JiangsuAges 16–65 - NCT07072221Recruiting
Matching drugs trial for relapsed T-cell lymphoma
This trial tests a combination of three drugs (bendamustine, chidamide, and lenalidomide) for patients with peripheral T-cell lymphoma that has come back or not responded to treatment. It aims to see if this new combination can help when standard treatments have failed.
Suzhou, JiangsuAges 18 years+ - NCT07072494RecruitingPhase 1/Phase 2
CD19 CAR-T cells as consolidation for B-cell ALL
This trial tests a single infusion of CD19 CAR-T cells as a consolidation treatment to keep leukemia in remission for patients who are not eligible for or decline a stem cell transplant. The goal is to see if this therapy can prevent relapse.
Guangzhou, GuangdongAges 14–80 - NCT07072858Recruiting
Heart MRI to Predict Recovery After Heart Attack
This study is testing if a special heart MRI taken within a week of a STEMI heart attack can help doctors predict your recovery and future risks. It may help tailor your follow-up care.
BeijingAges 18–80 - NCT07072910RecruitingPhase 2
Cabergoline for migraine prevention
This trial tests if a once-weekly medication called cabergoline can reduce how often you get migraine headaches. It is for adults who have between 4 and 14 migraine days per month.
Aarhus NAges 18 years+ - NCT07073027Recruiting
How digital media affects kids' healthcare experiences
This study looks at how using digital media (like videos or apps) before or during a hospital procedure affects kids' experiences. If you have a smartphone and a procedure coming up, you may be able to join.
Vancouver, British ColumbiaAges 5–23 - NCT07073066Recruiting
Lymphatic surgery for Alzheimer's disease (CLEAN-AD trial)
This trial tests a surgical procedure that connects lymphatic vessels in the neck to help clear waste from the brain in people with moderate-to-severe Alzheimer's disease. The goal is to see if this can improve thinking and memory.
Dongguan, GuangdongAges 50–80 - NCT07073248Recruiting
Brain stimulation for arm recovery after stroke
This trial uses a non-invasive brain stimulation technique called iTBS to see if it can improve arm and hand movement in people who have had a stroke more than 6 months ago. It might help you regain some function in your weaker arm.
StockholmAges 18 years+ - NCT07073235Recruiting
Brain stimulation to help leg movement after chronic stroke
This trial is testing if a non-invasive brain stimulation technique, called iTBS, can improve leg movement in people who have had a stroke more than six months ago and still have some weakness on one side.
StockholmAges 18 years+ - NCT07073365RecruitingPhase 2
Adding local therapy after osimertinib plus chemo for EGFR lung cancer
This trial tests whether directly treating the remaining lung tumor with surgery or radiation, after initial chemo and osimertinib, can improve outcomes for people with advanced EGFR-mutant non-small cell lung cancer.
BusanAges 20 years+ - NCT07073612Recruiting
Fontan stent study for liver stiffness and exercise
This study looks at whether placing a stent in the Fontan blood vessel can improve liver health and exercise ability in teenagers and young adults. If you are between 12 and 21 years old and need a stent in your Fontan pathway, you may be able to join.
Los Angeles, CaliforniaAges 12–21 - NCT07073586Recruiting
Lymphovenous anastomosis for leg lymphedema
This trial tests if a surgical procedure called lymphovenous anastomosis (LVA) can reduce swelling in the leg caused by lymphedema. It's for people with mild to moderate lymphedema who have been cancer-free for at least one year.
Odense, FynAges 18 years+ - NCT07073755Recruiting
Study of next treatments after targeted therapy resistance for advanced breast cancer
This study looks at what happens when people with advanced breast cancer switch to a new treatment after their cancer becomes resistant to targeted therapies like CDK4/6 inhibitors, PIK3CA inhibitors, or T-DXd. Researchers want to understand which next treatments work best in real life.
Changsha, HunanAges 18 years+ - NCT07074015Recruiting
AI tool to find sperm in surgery samples for male infertility
This study tests an artificial intelligence tool that helps doctors find very rare sperm in tissue removed during sperm retrieval surgery. If you have non-obstructive azoospermia (no sperm in your semen) and are having micro-TESE surgery, the AI might help find sperm that standard methods miss.
Boston, MassachusettsAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.